An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 10,551 | 9,316 | 10,040 | 7,216 | 11,537 |
| Operating Income | -10,551 | -9,316 | -10,040 | -7,216 | -11,537 |
| Other Income | 523 | 606 | 687 | 754 | 888 |
| Pre-tax Income | -10,028 | -8,710 | -9,353 | -6,462 | -10,649 |
| Net Income Continuous | -10,028 | -8,710 | -9,353 | -6,462 | -10,649 |
| Net Income | $-10,028 | $-8,710 | $-9,353 | $-6,462 | $-10,649 |
| EPS Basic Total Ops | -0.29 | -0.29 | -0.31 | -0.21 | -0.35 |
| EPS Basic Continuous Ops | -0.29 | -0.29 | -0.31 | -0.21 | -0.35 |
| EPS Diluted Total Ops | -0.29 | -0.29 | -0.31 | -0.21 | -0.35 |
| EPS Diluted Continuous Ops | -0.29 | -0.29 | -0.31 | -0.21 | -0.35 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.29 | -0.31 | -0.21 | -0.35 |
| EBITDA(a) | $-10,632 | $-9,433 | $-10,251 | $-7,515 | $-11,980 |